MKDTY (Molecular Data) YoY EBITDA Growth: 100.00% (As of Jun. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Molecular Data YoY EBITDA Growth?

Molecular Data MKDTY -99.90% YoY EBITDA Growth is 100.00% as of Jun. 2021.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Molecular Data's YoY EBITDA Growth for the quarter that ended in Jun. 2021 was 100.00%.

Molecular Data's EBITDA per Share for the three months ended in Jun. 2021 was $0.00.

Molecular Data YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Molecular Data's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Data YoY EBITDA Growth Chart

Molecular Data Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
YoY EBITDA Growth
0.00 10.15 -149.49 13.16 -49.41

Molecular Data Quarterly Data
Dec17 Dec18 Sep19 Dec19 Jun20 Dec20 Jun21 Sep21
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 0.00 100.00 100.00 100.00

Molecular Data YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Molecular Data's YoY EBITDA Growth for the fiscal year that ended in Dec. 2020 is calculated as:

YoY EBITDA Growth (A: Dec. 2020 )
=(EBITDA per Share (A: Dec. 2020 )-EBITDA per Share (A: Dec. 2019 ))/ | EBITDA per Share (A: Dec. 2019 ) |
=(-5.73--3.835)/ | -3.835 |
=-49.41 %

Molecular Data's YoY EBITDA Growth for the quarter that ended in Jun. 2021 is calculated as:

YoY EBITDA Growth (Q: Jun. 2021 )
=(EBITDA per Share (Q: Jun. 2021 )-EBITDA per Share (Q: Sep. 2019 )) / | EBITDA per Share (Q: Sep. 2019 )) |
=(0--0.547)/ | -0.547 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 100.00% mean?
Molecular Data (MKDTY) has a YoY EBITDA Growth of 100.00% as of Jun. 2021. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Molecular Data and its competitors.
Is Molecular Data's YoY EBITDA Growth too high?
Molecular Data's current YoY EBITDA Growth is 100.00%.
How does Molecular Data's YoY EBITDA Growth compare to BLGO and DOW?
Molecular Data's YoY EBITDA Growth of 100.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Molecular Data and its competitors. Molecular Data's current YoY EBITDA Growth is 100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Data stock overvalued right now?
Molecular Data (MKDTY) has a current YoY EBITDA Growth of 100.00%. The current YoY EBITDA Growth is 100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Molecular Data (MKDTY), the current YoY EBITDA Growth is 100.00% as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Data Business Description

Address 2177 Shenkun Road, 11th Floor, Building 15, Minhang District, Shanghai, CHN, 201106
Molecular Data Inc is a chemical e-commerce platform in China. It provides SaaS-powered and data-driven integrated service platform for chemical e-commerce. The company offers e-commerce solutions, financial solutions, and warehousing and logistics solutions through its platform. The company generates all its revenues through Chemical trading from China. It sells chemical products to customers through an online platform or sales representatives.